Literature DB >> 12441827

An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms.

Robert H Dworkin1.   

Abstract

OBJECTIVE: An overview is presented of neuropathic pain syndromes, their characteristic symptoms and signs, and recent approaches to identifying their pathophysiologic mechanisms.
DESIGN: The results of recent clinical studies of neuropathic pain are reviewed. Chronic neuropathic pain syndromes are emphasized because these long-lasting and often disabling conditions present a much greater challenge for the clinician than acute pain. Peripheral neuropathic syndromes have received greater attention in the research literature than central pain, and studies of syndromes such as postherpetic neuralgia and painful diabetic neuropathy provide the basis for current knowledge of neuropathic pain.
CONCLUSIONS: Precise estimates of the prevalence of neuropathic pain are not available, but chronic neuropathic pain may be much more common than has generally been appreciated and its prevalence can be expected to increase in the future. There is considerable agreement that both peripheral and central processes contribute to many chronic neuropathic pain syndromes, and that these different mechanisms may explain the qualitatively different symptoms and signs that patients experience. The limitations of existing treatments for neuropathic pain and the inability to provide relief for many patients has stimulated ongoing studies that examine different approaches to preventing neuropathic pain.

Entities:  

Mesh:

Year:  2002        PMID: 12441827     DOI: 10.1097/00002508-200211000-00001

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  65 in total

Review 1.  Epidemiology of neuropathic pain and its impact on quality of life.

Authors:  Blair H Smith; Nicola Torrance
Journal:  Curr Pain Headache Rep       Date:  2012-06

2.  Peripheral nerve stimulation for trigeminal neuropathic pain.

Authors:  David A Stidd; Adam L Wuollet; Kirk Bowden; Theodore Price; Amol Patwardhan; Steve Barker; Martin E Weinand; Jeffrey Annabi; Emil Annabi
Journal:  Pain Physician       Date:  2012 Jan-Feb       Impact factor: 4.965

3.  Painful neuropathic disorders: an analysis of the Régie de l'Assurance Maladie du Québec database.

Authors:  J Lachaine; A Gordon; M Choinière; J P Collet; D Dion; J-E Tarride
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

4.  Economic impact of shifting the locus of care for neuropathic pain from specialists to general practitioners.

Authors:  Ariel Berger; Piotr Kramarz; Gry Stine Kopperud; John Edelsberg; Gerry Oster
Journal:  Eur J Health Econ       Date:  2007-01-13

Review 5.  The pharmacotherapy of chronic pain: a review.

Authors:  Mary E Lynch; C Peter N Watson
Journal:  Pain Res Manag       Date:  2006       Impact factor: 3.037

6.  [Preoperative, neuropathic component in patients with back pain].

Authors:  Y-J Lee; E M W Koch; J B Breidebach; R Bornemann; D C Wirtz; R Pflugmacher
Journal:  Schmerz       Date:  2017-04       Impact factor: 1.107

7.  A case of diabetic neuropathy combined with Guillain-Barre syndrome.

Authors:  Heung-Yong Jin; Kyung-Ae Lee; So-Young Kim; Ji-Hyun Park; Hong-Sun Baek; Tae-Sun Park
Journal:  Korean J Intern Med       Date:  2010-06-01       Impact factor: 2.884

8.  Use of tricyclic antidepressants in older patients with painful neuropathies.

Authors:  Ariel Berger; Ellen M Dukes; John Edelsberg; Brett R Stacey; Gerry Oster
Journal:  Eur J Clin Pharmacol       Date:  2006-06-27       Impact factor: 2.953

Review 9.  Towards a theory of chronic pain.

Authors:  A Vania Apkarian; Marwan N Baliki; Paul Y Geha
Journal:  Prog Neurobiol       Date:  2008-10-05       Impact factor: 11.685

10.  Behavioral, medical imaging and histopathological features of a new rat model of bone cancer pain.

Authors:  Louis Doré-Savard; Valérie Otis; Karine Belleville; Myriam Lemire; Mélanie Archambault; Luc Tremblay; Jean-François Beaudoin; Nicolas Beaudet; Roger Lecomte; Martin Lepage; Louis Gendron; Philippe Sarret
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.